CRIO Secures Series A Financing to Accelerate Growth and Platform Development

CRIO Secures Series A Financing to Accelerate Growth and Platform Development
News provided by
Share this article
Share this article
BOSTON, March 11, 2021 /PRNewswire/ -- Clinical Research IO (CRIO), a Boston-based technology firm offering clinical research sponsors and sites a platform to streamline clinical trials, announced the completion of a $3.5 million Series A round led by Rally Ventures. 
The round allows CRIO to expand its product and engineering teams to develop the next wave of products. "Our goal has always been to streamline clinical research," said Raymond Nomizu, company co-founder and CEO. "To do this, we need to ramp up our product and engineering teams. We have laid the groundwork with our unparalleled site network of electronic adopters, and now we want to leverage this to unlock efficiencies for sponsors and contract research organizations (CROs)."

Related Keywords

Boston , Massachusetts , United States , Daenya Mcdonald , Raymond Chang , Ren Roome , Raymond Nomizu , Mark Lacy , Tom Peterson , Prnewswire Clinical Research , Venture Partner , Boston Millennia Partners , Benchmark Research , Crio , போஸ்டன் , மாசசூசெட்ஸ் , ஒன்றுபட்டது மாநிலங்களில் , ரேமஂட் சாங் , குறி லேசி , டோம் பீட்டர்சன் , துணிகர கூட்டாளர் , போஸ்டன் ஆயிரக்கணக்கான கூட்டாளர்கள் , பெஞ்ச்மார்க் ஆராய்ச்சி , சிறிய ,